Diadema-Partners-Lp
AI_NATIVE detailed information: This accession holds the following tickers:[ "OCUL", "ASND", "EWTX", "TRVI", "CNTA", "NKTR", "ARGX", "JAZZ", "TGTX", "PCRX", "ALNY", "FOLD", "MREO", "RXRX", "SWTX", "ANAB", "ALT", "OLMA", "RLAY", "TERN", "SMMT", "REPL", "KROS", "SAGE", "ALEC", "SRRK", "APGE", "NBIX", "KALV", "MNKD", "PRQR", "SGMT", "UBX", "ATYR", "ZYME", "PFE", "AMGN", "REGN", "AGIO", "MRNA", "RYTM", "SLNO", "QURE", "COGT", "ETNB", "RVPH", "GOSS", null, "ELDN", "EOLS", "IMCR", "IMUX", "NVO", "URGN", "VERV", "VTGN", "VKTX", "VRDN", "RARE", "PCVX", "BMEA", "BMRN", "BBIO", "CADL", "CRDF", "CAPR", "SAVA", "CMPX", "CORT", "CRSP", "CYTK", "LLY" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 72
- Total Value
- 201693517
- Accession Number
- 0001892688-25-000116
- Form Type
- 13F-HR
- Manager Name
- Diadema-Partners-Lp
Data Enrichment
99% identified71 identified1 unidentified
Holdings
72 positions • $201.7M total value
Manager:
Search and click to pin securities to the top
Page 4 of 4
Shares:346.9K
Value:$360.8K
% of Portfolio:0.2% ($360.8K/$201.7M)
Shares:131.4K
Value:$344.3K
% of Portfolio:0.2% ($344.3K/$201.7M)
Shares:30.3K
Value:$287.5K
% of Portfolio:0.1% ($287.5K/$201.7M)
Shares:207.7K
Value:$276.2K
% of Portfolio:0.1% ($276.2K/$201.7M)
Shares:64.6K
Value:$219.0K
% of Portfolio:0.1% ($219.0K/$201.7M)
Shares:56.1K
Value:$154.8K
% of Portfolio:0.1% ($154.8K/$201.7M)
Shares:46.0K
Value:$150.0K
% of Portfolio:0.1% ($150.0K/$201.7M)
Shares:25.0K
Value:$141.5K
% of Portfolio:0.1% ($141.5K/$201.7M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
346.9K | QoQ NEW(+346.9K) YoY- | All Managers (Combined) | $360.8K | 0.2% ($360.8K/$201.7M) | QoQ NEW(+$360.8K) YoY- | |
IMMUNIC, INC.(IMUXcusip4525EP101) | 317.8K | QoQ NEW(+317.8K) YoY- | All Managers (Combined) | $346.4K | 0.2% ($346.4K/$201.7M) | QoQ NEW(+$346.4K) YoY- |
131.4K | YoY- | All Managers (Combined) | $344.3K | 0.2% ($344.3K/$201.7M) | YoY- | |
30.3K | YoY- | All Managers (Combined) | $287.5K | 0.1% ($287.5K/$201.7M) | YoY- | |
207.7K | YoY- | All Managers (Combined) | $276.2K | 0.1% ($276.2K/$201.7M) | YoY- | |
64.6K | YoY- | All Managers (Combined) | $219.0K | 0.1% ($219.0K/$201.7M) | YoY- | |
aTYR PHARMA INC(ATYRcusip002120202) | 54.7K | QoQ NEW(+54.7K) YoY- | All Managers (Combined) | $165.2K | 0.1% ($165.2K/$201.7M) | QoQ NEW(+$165.2K) YoY- |
56.1K | YoY- | All Managers (Combined) | $154.8K | 0.1% ($154.8K/$201.7M) | YoY- | |
46.0K | QoQ NEW(+46.0K) YoY- | All Managers (Combined) | $150.0K | 0.1% ($150.0K/$201.7M) | QoQ NEW(+$150.0K) YoY- | |
25.0K | YoY- | All Managers (Combined) | $141.5K | 0.1% ($141.5K/$201.7M) | YoY- | |
100 | YoY- | All Managers (Combined) | $12.4K | 0.0% ($12.4K/$201.7M) | YoY- | |
200 | QoQ 0.00% (-0)YoY- | All Managers (Combined) | $500 | 0.0% ($500/$201.7M) | YoY- |